(Q84032484)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543468%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Finding the sweet spot: the role of nature and nurture in medicinal chemistry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543468%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543468%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Michael M Hann

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543468%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

30 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543468%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543468%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543468%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543468%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

355-365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543468%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrd3701

30 January 2020

exact match

0 references

cites work

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

A comparison of physiochemical property profiles of development and marketed oral drugs

31 March 2020

1 reference

31 March 2020

1 reference

Calculation of molecular lipophilicity: State-of-the-art and comparison of log P methods on more than 96,000 compounds

31 March 2020

1 reference

Is there a difference between leads and drugs? A historical perspective

31 March 2020

1 reference

Molecular complexity and its impact on the probability of finding leads for drug discovery

31 March 2020

1 reference

Pursuing the leadlikeness concept in pharmaceutical research.

31 March 2020

1 reference

The influence of drug-like concepts on decision-making in medicinal chemistry

31 March 2020

1 reference

Lipophilicity in drug discovery

31 March 2020

1 reference

Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability

31 March 2020

1 reference

Generation of a set of simple, interpretable ADMET rules of thumb

31 March 2020

1 reference

Probing the links between in vitro potency, ADMET and physicochemical parameters.

31 March 2020

1 reference

Ligand efficiency: a useful metric for lead selection

31 March 2020

1 reference

The influence of lead discovery strategies on the properties of drug candidates

31 March 2020

1 reference

Thermodynamics guided lead discovery and optimization.

31 March 2020

1 reference

The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds

31 March 2020

1 reference

Dependence of molecular properties on proteomic family for marketed oral drugs

31 March 2020

1 reference

Global mapping of pharmacological space

31 March 2020

1 reference

Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffolds

31 March 2020

1 reference

A structural biology view of target drugability.

31 March 2020

1 reference

Fragment screening to predict druggability (ligandability) and lead discovery success.

31 March 2020

1 reference

Predicting protein druggability

31 March 2020

1 reference

How were new medicines discovered?

31 March 2020

1 reference

The influence of the 'organizational factor' on compound quality in drug discovery

31 March 2020

1 reference

Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds

31 March 2020

1 reference

The rise of fragment-based drug discovery

31 March 2020

1 reference

Impact of high-throughput screening in biomedical research

31 March 2020

1 reference

Molecular complexity and fragment-based drug discovery: ten years on.

31 March 2020

1 reference

The Thermodynamics of Protein–Ligand Interaction and Solvation: Insights for Ligand Design

31 March 2020

1 reference

BINANA: a novel algorithm for ligand-binding characterization

31 March 2020

1 reference

Adding calorimetric data to decision making in lead discovery: a hot tip

31 March 2020

1 reference

Congeneric but still distinct: how closely related trypsin ligands exhibit different thermodynamic and structural properties

31 March 2020

1 reference

Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase

31 March 2020

1 reference

Enthalpic efficiency of ligand binding

31 March 2020

1 reference

How many drug targets are there?

31 March 2020

1 reference

Designed multiple ligands. An emerging drug discovery paradigm

31 March 2020

1 reference

Extent of enthalpy-entropy compensation in protein-ligand interactions.

31 March 2020

1 reference

Drug-target residence time and its implications for lead optimization

31 March 2020

1 reference

Shielded hydrogen bonds as structural determinants of binding kinetics: application in drug design

31 March 2020

1 reference

Ligand binding efficiency: trends, physical basis, and implications

31 March 2020

1 reference

Thermodynamics of ligand binding and efficiency

31 March 2020

1 reference

Simple size-independent measure of ligand efficiency

31 March 2020

1 reference

Assessing the lipophilicity of fragments and early hits.

31 March 2020

1 reference

Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes

31 March 2020

1 reference

Impact of lipophilic efficiency on compound quality

31 March 2020

1 reference

Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties

31 March 2020

1 reference

Drug efficiency: a new concept to guide lead optimization programs towards the selection of better clinical candidates

31 March 2020

1 reference

Application of drug efficiency index in drug discovery: a strategy towards low therapeutic dose.

31 March 2020

1 reference

Quantifying the chemical beauty of drugs.

31 March 2020

1 reference

Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States

31 March 2020

1 reference

Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries).

31 March 2020

1 reference

The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates.

31 March 2020

1 reference

What do medicinal chemists actually make? A 50-year retrospective

31 March 2020

1 reference

Heteroaromatic rings of the future.

31 March 2020

1 reference

Ten key issues in modern flow chemistry

31 March 2020

1 reference

Lead-oriented synthesis: a new opportunity for synthetic chemistry

31 March 2020

1 reference

Diversity-oriented synthesis: exploring the intersections between chemistry and biology

31 March 2020

1 reference

Collective synthesis of natural products by means of organocascade catalysis

31 March 2020

1 reference

Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity

31 March 2020

1 reference

Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity

31 March 2020

1 reference

Physiochemical drug properties associated with in vivo toxicological outcomes

31 March 2020

1 reference

How to improve R&D productivity: the pharmaceutical industry's grand challenge

31 March 2020

1 reference

An assessment of R&D productivity in the pharmaceutical industry

31 March 2020

1 reference

The developability classification system: application of biopharmaceutics concepts to formulation development

31 March 2020

1 reference

Drug discovery in the next decade: innovation needed ASAP.

31 March 2020

1 reference

Ligand efficiency indices as guideposts for drug discovery.

31 March 2020

1 reference

Two 'Golden Ratio' indices in fragment-based drug discovery

31 March 2020

1 reference

Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I).

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22543468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22543468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRD3701

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22543468%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference